Dr. Kris Ren Kawamoto, MD

Dr. Kawamoto practices at Straub Benioff Medical Center in Honolulu, Hawaii, part of Hawaiʻi Pacific Health.

Dr. Kawamoto's NPI, 1649618844, was assigned on June 10, 2013. Dr. Kawamoto graduated from University of Hawaii John A. Burns School of Medicine in 2013. Dr. Kawamoto holds Hawaii license MD-21925.

Dr. Kawamoto's primary practice is Straub Benioff Medical Center, at 888 S King Street, Honolulu, HI 96813 in Honolulu County. The practice phone is (808) 522-4000.

Dr. Kawamoto's primary practice is Straub Benioff Medical Center in Honolulu, Hawaii, part of Hawaiʻi Pacific Health. Dr. Kawamoto is also affiliated with The Queen's Medical Center. The medical group on file is The Queen's Medical Center. Dmand AI also links Dr. Kawamoto to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kawamoto practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kawamoto's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Kawamoto's licenses on file in 2 states: Hawaii and Michigan.

CMS data shows 265 Medicare services from Dr. Kawamoto across 7 procedure codes in 2024, for 106 Medicare patients. Medicare paid $28,127 for them.

CMS counts 106 Medicare patients who saw Dr. Kawamoto in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kawamoto's median patient age at 73, with 32% women.

In 2024, Dr. Kawamoto wrote 75 Medicare Part D claims for 32 patients. 72% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $10,876 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Kawamoto for performance year 2024, reported through an alternative payment model (APM). Dr. Kawamoto accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kawamoto as offering telehealth. CMS counts 76 procedures of coronary angioplasty and stenting by Dr. Kawamoto, more than 93% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Kawamoto, published from 2020 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Acute Coronary Syndrome. Dr. Kawamoto's most frequent co-authors are Mansoor Amjad Arain, MD, Auras R. Atreya, MD and Nadia Razaq Sutton, MD.

CMS Open Payments shows 158 general payments to Dr. Kawamoto from 20 drug and device companies from 2018 to 2025. Travel and lodging make up the largest share, 41% of the total. Abbott Laboratories paid the most, $6,235.

Dr. Kawamoto graduated from University of Hawaii John A. Burns School of Medicine in 2013.